Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 91424-39-4 | MDL No. : | MFCD16251279 |
Formula : | C15H30O5Si | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | PPZUZFQSSULNGN-UHFFFAOYSA-N |
M.W : | 318.48 | Pubchem ID : | 13327289 |
Synonyms : |
|
Num. heavy atoms : | 21 |
Num. arom. heavy atoms : | 0 |
Fraction Csp3 : | 0.87 |
Num. rotatable bonds : | 11 |
Num. H-bond acceptors : | 5.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 85.74 |
TPSA : | 61.83 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.89 cm/s |
Log Po/w (iLOGP) : | 3.36 |
Log Po/w (XLOGP3) : | 3.31 |
Log Po/w (WLOGP) : | 3.28 |
Log Po/w (MLOGP) : | 2.09 |
Log Po/w (SILICOS-IT) : | 1.83 |
Consensus Log Po/w : | 2.78 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 1.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -3.17 |
Solubility : | 0.213 mg/ml ; 0.00067 mol/l |
Class : | Soluble |
Log S (Ali) : | -4.28 |
Solubility : | 0.0165 mg/ml ; 0.0000519 mol/l |
Class : | Moderately soluble |
Log S (SILICOS-IT) : | -3.51 |
Solubility : | 0.0984 mg/ml ; 0.000309 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 2.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 4.19 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P280-P301+P312-P302+P352-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
68% | With sodium hydroxide; acetic anhydride In methanol; diethyl ether; benzene | B. 4-[[(Dimethylethyl)dimethylsilyl]oxy]dihydro-2H-pyran-2,6(3H)-dione A solution of Part A silyl-ether (theory 63.6 g, 200 mmole) in methanol (200 ml) was treated with NaOH pellets (16.0 g, 400 mmole) and stirred at room temperature under argon for 18 hours. The cloudy yellow solution was evaporated to dryness and dried in vacuo to give the diNa salt as a pale yellow solid. The diNa salt (42.1 g) was suspended in benzene (400 ml), treated with acetic anhydride (200 ml) and refluxed under argon for 1.5 hours. The brown mixture was concentrated in vacuo and the residue partitioned between ethyl acetate and half-saturated NaHCO3 solution. The organic phase was washed with half saturated NaHCO3 and saturated NaCl solutions, dried over Na2 SO4 and evaporated to give the crude title anhydride as a brown solid. The crude product was taken up in ethyl ether, treated with Darco (3 g), filtered through Celite and evaporated. The crystalline residue was triturated with cold hexane to give pure title anhydride (33.26 g, 68percent overall from diethyl 3-hydroxy glutarate) as white plates, m.p. 77°-78° C., C13 -NMR (15 MHz, CDCl3)--5.22 ppm, 17.64, 25.31, 38.88, 61.87, 165.26. |
[ 91424-40-7 ]
3-(tert-Butyldimethylsilyloxy)glutaric anhydride
Similarity: 0.98
[ 676560-15-9 ]
Ethyl 4-((tert-butyldimethylsilyl)oxy)cyclohexanecarboxylate
Similarity: 0.89
[ 1341195-54-7 ]
Ethyl 4-((tert-butyldimethylsilyl)oxy)-3-oxobutanoate
Similarity: 0.81
[ 913258-07-8 ]
(3aR,4S,5R,6aS)-4-(Hydroxymethyl)-5-((triethylsilyl)oxy)hexahydro-2H-cyclopenta[b]furan-2-one
Similarity: 0.81